Iran, Islamic Republic of vs Latvia: New cases tested for RR-/MDR-TB
Iran, Islamic Republic of
80.0%
in 2024
Latvia
80.0%
in 2024
Iran, Islamic Republic of rank
127th
Latvia rank
127th
New cases tested for RR-/MDR-TB over time
- Iran, Islamic Republic of
- Latvia
How they compare
Iran, Islamic Republic of currently reports 80.0% against 80.0% in Latvia, a difference of 0.0%.
Across all 15 years both countries report, Latvia has been ahead every year.
Iran, Islamic Republic of ranks 127th and Latvia ranks 127th of 192 countries.
Latvia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Iran, Islamic Republic of | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.5% | 100.0% | 93.5% | Latvia |
| 2010s | 20.1% | 98.0% | 77.9% | Latvia |
| 2020s | 63.0% | 83.7% | 20.7% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Iran, Islamic Republic of or Latvia?
- Iran, Islamic Republic of, at 80.0% against 80.0% in Latvia as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Iran, Islamic Republic of and Latvia?
- 0.0%, with Iran, Islamic Republic of ahead.
- How many years of comparable data are there for Iran, Islamic Republic of and Latvia?
- 15 years are reported by both, from 2005 to 2024.
- How do Iran, Islamic Republic of and Latvia rank globally for new cases tested for rr-/mdr-tb?
- Iran, Islamic Republic of ranks 127th and Latvia ranks 127th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.